Labshake search
Citations for R&D Systems :
1201 - 1250 of 4238 citations for Human Immunodeficiency Virus GP41 Protein HIV 1 Clade B since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Cell Biology 2023Quote: ... and Human CXCL11/I-TAC Quantikine ELISA Kit (R&D Systems, Cat# DCX110), respectively ...
-
Suppression of the Integrated Stress Response in Islet β Cells Decreases Risk of Autoimmune DiabetesbioRxiv - Cell Biology 2023Quote: ... and 50 IU/mL human IL-1β (R&D Systems; 201-LB-005). EndoC-βH1 cells were transfected using Accell siRNA targeted against human GOLM1 (Horizon Discovery) ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Cancer Biology 2024Quote: ... or the Human M-CSF DuoSet ELISA kit (cat# DY216, R&D Systems). The concentration of protein secreted was interpolated from the standard curve measurements.
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human Interferon alpha 2a (IFN-alpha) was purchased from R&D systems. Cisplatin was purchased from Sigma-Aldrich.
-
bioRxiv - Cancer Biology 2024Quote: ... rabbit anti Human Phospho-p27/Kip1 Threonine 157 (Cat# AF1555, R&D Systems).
-
bioRxiv - Genomics 2022Quote: Circulating AAV-expressed human ANGPTL3 protein levels were measured from plasma using commercially-available ELISA kits (plasma diluted 1:4 and used with R&D Systems #DANL30). The assay is specific for detection of human ANGPTL3 protein ...
-
bioRxiv - Neuroscience 2023Quote: ... Primary antibodies targeting the following proteins were used at the indicated dilutions and obtained from the denoted companies: Robo3 1:300 (R&D systems, #AF3155), GluN1 NMDAR 1:1000 (SySy #114011) ...
-
bioRxiv - Neuroscience 2021Quote: ... and with BSA as a carrier protein to enhance protein stability for in-vitro studies (R&D Systems; 458-MF). Leptin was obtained from the National Hormone and Peptide Program (Dr ...
-
bioRxiv - Neuroscience 2023Quote: ... A beveled glass needle was pre-loaded with mineral oil and the recombinant human IL-1 receptor inhibitor (IL-1RA, R&D Systems, Cat # 280-RA, resuspended in 0.1% BSA), then positioned in the injecting rig at a 90° angle relative to the horizontal plane of the Petri dish and head mold ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1.7 ng hrWnt11 protein (R&D Systems) or BSA (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2021Quote: ... mouse RANKL protein (R&D systems, 462-TEC), mouse M-CSF (R&D systems ...
-
bioRxiv - Cell Biology 2020Quote: ... recombinant protein of mouse BMP4 (R&D Systems) was added to the medium 16 h before analysis.
-
bioRxiv - Cell Biology 2020Quote: ... Tamm-Horsfall protein (cat# AF5144, R&D Systems), CD45 (clone HI30,cat# 304002,) ...
-
bioRxiv - Developmental Biology 2022Quote: ... Recombinant FREM1 protein (R&D Systems, Minneapolis, MN) dissolved in DPBS was diluted to final concentrations of 7.5 µg/mL ...
-
bioRxiv - Developmental Biology 2022Quote: ... Recombinant FREM1 protein (R&D Systems, Minneapolis, MN) dissolved in DPBS was diluted to final concentrations of 7.5 µg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... or ErBb2-Fc fusion proteins (R&D Systems) for 30 min on ice ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant proteins were purchased from R&D Systems: EDA-A1 (3944-ED) ...
-
bioRxiv - Cell Biology 2023Quote: ... where recombinant Wnt5a protein (rWnt5a, R&D Systems) is added to ENR at a final concentration of 200 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... ex vivo primary B cells were first cultured for 12 h in complete media supplemented with 5 ng/ml BAFF (R&D Systems) and 2.5 µg/ml Escherichia coli O111:B4 LPS (Millipore Sigma ...
-
bioRxiv - Developmental Biology 2019Quote: ... in Medium B with the addition of 5 U/mL erythropoietin (EPO; Amgen) and 5 ng/mL interleukin-3 (IL3; R&D Systems). Two days later ...
-
bioRxiv - Cancer Biology 2021Quote: SUM159-LM1 cells or MDA231-LM2 cells were suspended in HuMEC/0.1% BSA and treated with EC-derived conditioned media (CM) (diluted 2-5 times in the final medium) or 50 ng/ml of recombinant activin B (R&D systems). 2,500 cells/well of SUM159-LM1 cells or 5,000 cells/well of MDA231-LM2 cells were seeded on 96-well ultra-low attachment plate (Corning) ...
-
bioRxiv - Cell Biology 2020Quote: ... B-27 Serum-Free Supplement (50x) (Cat. No. 17504044, Life Technology) + 50 ng/ml FGF7 (Cat. No. 251-KG, R&D System) for 2 days ...
-
bioRxiv - Neuroscience 2022Quote: ... We used 250 µg of cell lysates for each of the parts A and B of the array and followed manufacturers’ instructions (R&D Systems).
-
bioRxiv - Immunology 2023Quote: ... cells were initially activated at 5 x 105 cells/mL in B cell activation media: 5 µg/mL soluble CD40L (R&D Systems), 10 µg/mL anti-His tag antibody (clone AD1.1.10 ...
-
bioRxiv - Immunology 2022Quote: ... The single memory B cells were cultured in complete RPMI 1640 medium supplemented with IL-2 (10 U/ml, R&D Systems), IL-21 (10 U/ml ...
-
bioRxiv - Pathology 2020Quote: ... SR-AI and CD-36 proteins were pulled down from MΦ membrane extracts as described above for TLR-4 using anti-SR-A (R&D System, 1:1000) and anti-CD36 (R&D System ...
-
bioRxiv - Bioengineering 2020Quote: ... medium was removed and the scaffolds designated for study in normal growth media were placed in wells with fresh normal growth medium and the mineralized collagen-AM scaffolds designated for study in inflammatory conditions were placed in wells with inflammatory medium (1 ng/ml of IL-1β recombinant porcine protein (R&D Systems, Minneapolis, MN) added to normal growth media) ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2020Quote: ... Gas1 was stained using goat anti-human Gas1 antibodies (R&D systems, Cat# AF2636). Dhh was stained using mouse anti-Dhh antibodies (Santa Cruz Biotechnology ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... The following antibodies were used: Human alpha-Smooth Muscle Actin (R&D Systems, MAB1420), Human/Mouse alpha-Fetoprotein/AFP (R&D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... PDGF-AB were determined by Human Magnetic Luminex Assays (R&D Systems, Minneapolis, MN) according to manufacturer’s protocol.
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... and DuoSet Human IFN-gamma kit and Ancillary Reagent Kit 2 (R&D Systems) were performed according to manufacturer’s instructions ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Neuroscience 2019Quote: Recombinant human IDO (Accession #P14902) was obtained from R&D Systems (#6030-AO-010) and frozen at −80°C until use ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant mouse interferon-γ and recombinant human interkeukin-8 (R&D Systems, Minneapolis, MN) was prepared in PBS containing 0.1% BSA ...
-
bioRxiv - Neuroscience 2020Quote: ... then labelled with and without anti-human LILRB2 (5 µg/mL; R&D Systems). The cells were washed with PBS (0.5% BSA ...
-
bioRxiv - Bioengineering 2020Quote: Proteome Profiler Antibody Array Kits for human angiogenesis factors (R&D systems, MN, USA) were used for reverse western blot ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Biochemistry 2020Quote: The mouse and human anti-CHL1 antibodies (AF2147 and MAB2126; R&D systems, MN) were partially reduced and bound to HRP using a peroxidase labeling kit SH (Dojindo ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...